10x Genomics (TXG) Total Debt Growth (1y) (2019)
Analysis
10x Genomics (TXG) Total Debt Growth (1y) (2019) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 226.93 Bn | 222.99 Bn | 8.34 Bn | 22.57% |
| 2 | Danaher | 145.94 Bn | 141.60 Bn | 3.61 Bn | 56.63% |
| 3 | Agilent Technologies | 42.55 Bn | 40.79 Bn | 1.04 Bn | 22.64% |
| 4 | Illumina | 32.95 Bn | 31.78 Bn | 770.00 Mn | 0.00% |
| 5 | Revvity | 14.53 Bn | 13.51 Bn | 416.87 Mn | -0.29% |
| 6 | Bio-Techne | 11.31 Bn | 11.04 Bn | 211.39 Mn | -42.20% |
| 7 | Bio-Rad Laboratories | 10.34 Bn | 8.72 Bn | 345.80 Mn | 33.43% |
| 8 | Repligen | 9.46 Bn | 8.44 Bn | 110.04 Mn | 3,759.78% |
| 9 | Bruker | 8.91 Bn | 8.73 Bn | 416.00 Mn | -25.07% |
| 10 | 10x Genomics | 8.16 Bn | 7.61 Bn | 112.50 Mn | - |